These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2287790)
1. Pathophysiology and treatment of seasonal allergic rhinitis. Bousquet J; Chanez P; Michel FB Respir Med; 1990 Nov; 84 Suppl A():11-7. PubMed ID: 2287790 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of allergic rhinitis. Delafuente JC; Davis TA; Davis JA Clin Pharm; 1989 Jul; 8(7):474-85. PubMed ID: 2666011 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Karaki M; Akiyama K; Mori N Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Allergic Rhinitis in Clinical Practice. Tosca MA; Trincianti C; Naso M; Nosratian V; Ciprandi G Curr Pediatr Rev; 2024; 20(3):271-277. PubMed ID: 37702169 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057 [TBL] [Abstract][Full Text] [Related]
9. Treatment of allergic rhinitis: H1-antihistamines and intranasal steroids. Wang DY Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):215-20. PubMed ID: 14561186 [TBL] [Abstract][Full Text] [Related]
10. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203 [TBL] [Abstract][Full Text] [Related]
11. Evaluation and management of allergic rhinitis. Hadley JA Med Clin North Am; 1999 Jan; 83(1):13-25. PubMed ID: 9927957 [TBL] [Abstract][Full Text] [Related]
12. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Yáñez A; Rodrigo GJ Ann Allergy Asthma Immunol; 2002 Nov; 89(5):479-84. PubMed ID: 12452206 [TBL] [Abstract][Full Text] [Related]
13. Influences of allergic rhinitis on sleep. Ferguson BJ Otolaryngol Head Neck Surg; 2004 May; 130(5):617-29. PubMed ID: 15138430 [TBL] [Abstract][Full Text] [Related]
17. [Rhinitis in adults]. Kalogjera L Acta Med Croatica; 2011; 65(2):181-7. PubMed ID: 22359885 [TBL] [Abstract][Full Text] [Related]
18. Management of allergic rhinitis: focus on intranasal agents. Dushay ME; Johnson CE Pharmacotherapy; 1989; 9(6):338-50. PubMed ID: 2575739 [TBL] [Abstract][Full Text] [Related]
19. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis. Edwards TB Clin Ther; 1995; 17(6):1032-41. PubMed ID: 8750396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]